Go Pro
→ They didn't warn anyone in 1971. This time someone is warning you. (From Reagan Gold Group) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
$34.52
+1.1%		$26.54
$3.32
▼
$35.41
$1.21B1.06375,226 shs194,784 shs
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
$0.00
$4.35
▼
$11.97
$1.01B4.52528,025 shs1.43 million shs
CytoDyn Inc. stock logo
CYDY
CytoDyn
$0.20
+1.3%		$0.23
$0.18
▼
$0.40
$273.79M1.181.82 million shs684,728 shs
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
C$12.34
C$12.45
C$4.55
▼
C$13.93
C$990.56MN/A219,805 shsN/A
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
+1.45%+18.82%+24.12%+64.64%+904.35%
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
0.00%0.00%0.00%0.00%0.00%
CytoDyn Inc. stock logo
CYDY
CytoDyn
-0.41%+4.69%-7.62%-43.82%-31.65%
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
0.00%0.00%0.00%+22.42%+62.16%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
$34.52
+1.1%		$26.54
$3.32
▼
$35.41
$1.21B1.06375,226 shs194,784 shs
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
$0.00
$4.35
▼
$11.97
$1.01B4.52528,025 shs1.43 million shs
CytoDyn Inc. stock logo
CYDY
CytoDyn
$0.20
+1.3%		$0.23
$0.18
▼
$0.40
$273.79M1.181.82 million shs684,728 shs
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
C$12.34
C$12.45
C$4.55
▼
C$13.93
C$990.56MN/A219,805 shsN/A
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
+1.45%+18.82%+24.12%+64.64%+904.35%
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
0.00%0.00%0.00%0.00%0.00%
CytoDyn Inc. stock logo
CYDY
CytoDyn
-0.41%+4.69%-7.62%-43.82%-31.65%
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
0.00%0.00%0.00%+22.42%+62.16%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
2.55
Moderate Buy$37.257.91% Upside
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
0.00
N/AN/AN/A
CytoDyn Inc. stock logo
CYDY
CytoDyn
0.00
N/AN/AN/A
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
2.00
HoldN/AN/A

Current Analyst Ratings Breakdown

Latest CYDY, CNTTF, ANRO, and GLASF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/17/2026
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$50.00 ➝ $55.00
8/13/2026
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
Wedbush logo
Wedbush
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$24.00 ➝ $26.00
8/13/2026
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$28.00 ➝ $37.00
7/29/2026
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/22/2026
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
6/17/2026
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
6/15/2026
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
5/27/2026
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$50.00
5/22/2026
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
Wolfe Research logo
Wolfe Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform
(Data available from 8/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
N/AN/AN/AN/A$4.87 per shareN/A
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
$15.96M0.00N/AN/AN/ANaN
CytoDyn Inc. stock logo
CYDY
CytoDyn
N/AN/AN/AN/A($0.08) per shareN/A
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
-$63.24M-$2.42N/AN/AN/AN/A-46.46%-39.09%N/A
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/A$0.07137.18N/AN/AN/AN/AN/AN/A
CytoDyn Inc. stock logo
CYDY
CytoDyn
$3.74M-$0.03N/AN/AN/AN/AN/A-182.93%N/A
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest CYDY, CNTTF, ANRO, and GLASF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
-$0.7345-$0.65+$0.0845-$0.65N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
N/AN/AN/AN/AN/A
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/AN/AN/AN/AN/A
CytoDyn Inc. stock logo
CYDY
CytoDyn
N/AN/AN/AN/AN/A
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
0.07
14.85
14.85
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/AN/AN/A
CytoDyn Inc. stock logo
CYDY
CytoDyn
N/A
0.37
0.37
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
N/A
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
0.08%
CytoDyn Inc. stock logo
CYDY
CytoDyn
5.06%
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
N/A

Insider Ownership

CompanyInsider Ownership
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
11.25%
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/A
CytoDyn Inc. stock logo
CYDY
CytoDyn
1.00%
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
N/A35.09 million31.15 millionN/A
CannTrust Holdings Inc stock logo
CNTTF
CannTrust
N/A105.61 millionN/ANot Optionable
CytoDyn Inc. stock logo
CYDY
CytoDyn
201.38 billion1.36 billionNot Optionable
Glass House Brands Inc. stock logo
GLASF
Glass House Brands
36280.27 millionN/ANot Optionable

Recent News About These Companies

Glass House Brands Retains Former DEA Compliance Executive to Advise on Interstate Commerce and Export Opportunities
July 27, 2026  |  financialpost.comF
Glass House Brands Appoints Matt Murphy as DEA Compliance Advisor to Support Interstate Commerce and Cannabis Export Initiatives
July 27, 2026  |  quiverquant.comQ
Glass House Brands Announces the Filing of an Updated At-The-Market Distribution Program
July 15, 2026  |  financialpost.comF
Glass House Brands Announces the Filing of an Updated At-The-Market Distribution Program
July 15, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/15/3327679/0/en/glass-house-brands-announces-the-filing-of-an-updated-at-the-market-distribution-program.html
Glass House Brands Completes First International Hemp Sale
July 7, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/07/3323058/0/en/glass-house-brands-completes-first-international-hemp-sale.html
Glass House Brands Announces Uplist to NYSE
June 25, 2026  |  financialpost.comF
Glass House Brands Announces Uplist to NYSE
June 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/25/3317437/0/en/glass-house-brands-announces-uplist-to-nyse.html
Glass House Brands Provides Notice of Warrant Acceleration
June 23, 2026  |  financialpost.comF
Glass House Brands Provides Notice of Warrant Acceleration
June 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/24/3316557/0/en/glass-house-brands-provides-notice-of-warrant-acceleration.html
Glass House Brands Announces Voting Results Following Annual Meeting
June 19, 2026  |  financialpost.comF
Glass House Brands Announces Voting Results Following Annual Meeting
June 19, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/19/3314709/0/en/glass-house-brands-announces-voting-results-following-annual-meeting.html
Glass House Brands Pursues NYSE Listing Path
June 17, 2026  |  kalkinemedia.comK
Glass House Brands Announces its Deconsolidation of its Dual-Use Business and its Application for Uplisting of Shares to NYSE
June 17, 2026  |  financialpost.comF
Glass House Brands files new base shelf prospectus; renews $100M ATM program
June 11, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/glass-house-brands-files-new-base-shelf-prospectus-renews-100m-atm-program/ar-AA25mkzh
Glass House Brands Announces the Filing of Shelf Prospectus and At-The-Market Distribution Program
June 10, 2026  |  financialpost.comF
Glass House Brands Completes Previously Announced Warrant Redemption
May 29, 2026  |  financialpost.comF
Glass House Brands Completes Previously Announced Warrant Redemption
May 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/29/3303509/0/en/glass-house-brands-completes-previously-announced-warrant-redemption.html
Glass House Brands to Host Investor Sesh V on Thursday, June 18, 2026
May 20, 2026  |  financialpost.comF
Glass House Brands to Host Investor Sesh V on Thursday, June 18, 2026
May 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/20/3298398/0/en/glass-house-brands-to-host-investor-sesh-v-on-thursday-june-18-2026.html
Glass House Brands Announces the Filing of Prospectus Supplement for Previously Announced At-The-Market Distribution Program
May 18, 2026  |  financialpost.comF

New MarketBeat Followers Over Time

Media Sentiment Over Time

Alto Neuroscience stock logo

Alto Neuroscience NYSE:ANRO

$34.52 +0.39 (+1.14%)
As of 03:15 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. Its product pipeline comprising ALTO-100, which is in phase 2b clinical trial for the treatment of patients with major depressive disorder (MDD); and which is in phase 2a clinical trial for the treatment of post-traumatic stress disorder. The company develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties which is in phase 2b clinical trial to treat patients with MDD; ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor which is in phase 1 clinical trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist which is in phase 1 clinical trial to treat patients with MDD and higher levels of anhedonia; and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor which is in phase 1 clinical trial for the treatment of MDD. In addition, it develops novel pharmacodynamically synergistic combination and biomarker platform that collects patient-specific data to identify biomarker-characterized patient. The company was incorporated in 2019 and is headquartered in Los Altos, California.

CannTrust stock logo

CannTrust OTCMKTS:CNTTF

CannTrust Holdings Inc. produces and distributes pharmaceutical grade medical cannabis products in Canada. It sells dried cannabis and oil extractions to the client based on the medication document provided by health care practitioner. The company has a partnership with Gold Coast University Hospital. CannTrust Holdings Inc. was incorporated in 2015 and is headquartered in Vaughan, Canada.

CytoDyn stock logo

CytoDyn OTCMKTS:CYDY

$0.20 +0.00 (+1.27%)
As of 02:52 PM Eastern

CytoDyn Inc., a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer. Its leronlimab is currently under phase 2 development for the treatment of NASH, HIV- NASH, and solid tumors, as well as under pre-clinical development for the treatment of HIV-PrEP and HIV-Cure. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.

Glass House Brands stock logo

Glass House Brands OTCMKTS:GLASF

C$12.34 0.00 (0.00%)
As of 08/18/2026

Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. The company operates in three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods. It cultivates, manufactures, and distributes cannabis bulk flowers and trims to wholesalers; and consumer packaged goods to third-party retail stores in California. The company also owns and operates retail cannabis stores. In addition, it offers raw cannabis, cannabis oil, and cannabis consumer goods; edibles; flower jars and bags; single, multi-pack, and infused pre-rolls; tinctures; biomass for distributors; and online payment processing, in-store pickup and home delivery services for adult-use and medicinal-use customers. The company offers its cannabis products under the Glass House Farms, FIELD, Forbidden Flowers, PLUS, Mama Sue, Allswell, and REEFORM brand names. Glass House Brands Inc. was founded in 2015 and is headquartered in Long Beach, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas